April 24, 2024
Stocks & Bonds
[STOCK WATCH] NeoPharm falls 1.41%
[THE INVESTOR] As of Aug. 16 11:55 A.M., NeoPharm declined 1.41%, compared with yesterday, to 28,050 won. It had declined 15.64% through the past month. Standard deviation, the variableness index, was 2.1% on the same period over one month.
Compared with its close competitors within the same industry, KOSDAQ, the monthly volatility of NeoPharm was at a low level, the earnings rate over one month was also the lowest with decline of stock price. Over the recent month, the return-on-risk, the return on investment with consideration about risk, was -7.4%. By tumbling of stock price, the return-on-risk is the lowest among its peer group in spite of low volatility. Moreover, compared with the KOSDAQ industry, the return-on-risk is below the industrial mean, -5.1, and thus the industrial comparison performance was not so good.
By HeRo (hero@heraldcorp.com)
This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp.
Compared with its close competitors within the same industry, KOSDAQ, the monthly volatility of NeoPharm was at a low level, the earnings rate over one month was also the lowest with decline of stock price. Over the recent month, the return-on-risk, the return on investment with consideration about risk, was -7.4%. By tumbling of stock price, the return-on-risk is the lowest among its peer group in spite of low volatility. Moreover, compared with the KOSDAQ industry, the return-on-risk is below the industrial mean, -5.1, and thus the industrial comparison performance was not so good.
By HeRo (hero@heraldcorp.com)
This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp.
![[Exclusive] Korean military set to ban iPhones over 'security' concerns](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=151&simg=/content/image/2024/04/23/20240423050599_0.jpg)
